scispace - formally typeset
M

Mark Slee

Researcher at Flinders University

Publications -  110
Citations -  5891

Mark Slee is an academic researcher from Flinders University. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 34, co-authored 91 publications receiving 4656 citations. Previous affiliations of Mark Slee include Katholieke Universiteit Leuven & John Radcliffe Hospital.

Papers
More filters
Journal ArticleDOI

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Ashley Beecham, +206 more
- 01 Nov 2013 - 
TL;DR: This study enhances the catalog of multiple sclerosis risk variants and illustrates the value of fine mapping in the resolution of GWAS signals.
Journal ArticleDOI

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

TL;DR: To identify multiple sclerosis (MS) susceptibility loci, a genome-wide association study in 1,618 cases and used shared data for 3,413 controls and observed a statistical interaction between SNPs in EVI5-RPL5 and HLA-DR15.
Journal ArticleDOI

Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis

TL;DR: The probability of conversion was lower when glatiramer acetate or interferon beta was started within 5 years of disease onset vs later, and initial treatment with fingolimod, alemtuzumab, or natalizumab was associated with a lower risk of conversion.
Journal ArticleDOI

Defining secondary progressive multiple sclerosis.

TL;DR: In this article, the authors evaluated the accuracy and feasibility of an objective definition for secondary progressive multiple sclerosis, to enable comparability of future research studies, using MSBase, a large, prospectively acquired, global cohort study, and analyzed the accuracy of 576 data-derived onset definitions for SPM and compared these to a consensus opinion of three neurologists.